((自动化翻译由路透提供，请见免责声明 ))
1月13日 - ** 疫苗制造商莫德纳 股价盘前下跌13.6%，至36.20美元。
** 受呼吸道合胞病毒(RSV) 疫苗上市缓慢和 COVID-19 疫苗需求疲软的影响，该公司将 (link) 2025 年的销售预期下调了 10 亿美元。
** 该公司预计年收入为 15 亿至 25 亿美元，低于此前预测的 25 亿至 35 亿美元。
** 根据 LSEG 的数据，分析师平均预期年收入为 29.5 亿美元
** 公司预计到 2025 年底，现金和投资额将达到 60 亿美元。
** 截至上次收盘，股价在过去 12 个月中下跌了 61.4
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.